Abstract:Nanotheranostic agents capable of simultaneously enabling real-time tracking and precise treatment at tumor sites play an increasingly pivotal role in the field of medicine. In this article, we report a novel near-infrared-II window (NIR-II) emitting downconversion rare-earth nanoparticles (RENPs) to improve image-guided therapy for breast cancer. The developed α-NaErF4@NaYF4 nanoparticles (α-Er NPs) have a diameter of approximately 24.1 nm and exhibit superior biocompatibility and negligible toxicity. RENPs exhibit superior imaging quality and photothermal conversion efficiency in the NIR-II range compared to clinically approved indocyanine green (ICG). Under 808 nm laser irradiation, the α-Er NPs achieve significant tumor imaging performance and photothermal effects in vivo in a mouse model of breast cancer. Simultaneously, it combines X-ray computed tomography (CT) and ultrasound (US) tri-modal imaging to guide therapy for cancer. The integration of NIR-II imaging technology and RENPs establishes a promising foundation for future medical applications.

What problem does this paper attempt to address?

This paper attempts to solve several key problems in the diagnosis and treatment of breast cancer: 1. **Improve the accurate identification of tumor boundaries during surgery**: One of the main challenges in breast cancer surgery is the unclear tumor boundaries, which makes it difficult to achieve complete resection. The paper proposes to use the second near - infrared (NIR - II) fluorescence imaging technology, through the down - conversion luminescence characteristics of rare - earth nanoparticles (α - Er NPs), to provide high - resolution and high - sensitivity real - time intraoperative imaging, so as to more accurately identify tumor boundaries. 2. **Integrated application of multi - modal imaging**: The application of a single imaging technique in surgery is often insufficient to distinguish between cancerous and non - cancerous areas. By combining three imaging techniques, namely NIR - II imaging, X - ray computed tomography (CT) and ultrasound (US), the paper has achieved multi - modal imaging of breast cancer, thereby providing more comprehensive tumor information and assisting doctors in more accurate diagnosis and treatment. 3. **Application of photothermal therapy**: The paper also explores the application of α - Er NPs in photothermal therapy (PTT). Under 808 nm laser irradiation, α - Er NPs can produce a significant photothermal effect, effectively kill tumor cells, and achieve non - invasive treatment of breast cancer. 4. **Biocompatibility and metabolic safety**: The study also evaluated the biocompatibility and in - vivo metabolic characteristics of α - Er NPs. The results show that these nanoparticles have good biocompatibility and can be mostly excreted out of the body within 72 hours through the liver clearance pathway, reducing potential toxic and side effects. In conclusion, this paper aims to develop a new type of rare - earth nanoparticle based on NIR - II fluorescence imaging and photothermal therapy, in order to improve the diagnostic accuracy and treatment effect of breast cancer, and provide new strategies and technical support for future clinical applications.

The Down-Shifting Luminescence of Rare-Earth Nanoparticles for Multimodal Imaging and Photothermal Therapy of Breast Cancer

A Novel TMTP1-modified Theranostic Nanoplatform for Targeted in Vivo NIR-II Fluorescence Imaging-guided Chemotherapy of Cervical Cancer

Early Tumor Detection Afforded by in Vivo Imaging of Near-Infrared Ii Fluorescence

Multifunctional Rbx WO3 Nanorods for Simultaneous Combined Chemo-Photothermal Therapy and Photoacoustic/ct Imaging.

Excretable Lanthanide Nanoparticle For Biomedical Imaging And Surgical Navigation In The Second Near-Infrared Window

Cancer Cell Membrane-Coated Rare Earth Doped Nanoparticles for Tumor Surgery Navigation in NIR-II Imaging Window

An Integrated Nanoplatform via Dual Channel Excitation for Both Precise Fluorescence Imaging and Photodynamic Therapy of Orthotopic Breast Tumor in NIR-II Region

In vivo molecular imaging for immunotherapy using ultra-bright near-infrared-IIb rare-earth nanoparticles

Tunable and Enhanced NIR-II Luminescence from Heavily Doped Rare-Earth Nanoparticles for in Vivo Bioimaging.

Upconversion and NIR-II luminescent rare earth nanoparticles combined with machine learning for cancer theranostics

Dual-modal Imaging-Guided Agent Based on NIR-II Aggregation-Induced Emission Luminogens with Balanced Phototheranostic Performance

Recent Advances on Rare Earth Upconversion Nanomaterials for Combined Tumor Near-Infrared Photoimmunotherapy

An Activatable Phototheranostic Nanoplatform for Tumor Specific NIR-II Fluorescence Imaging and Synergistic NIR-II Photothermal-Chemodynamic Therapy.

Lanthanide‐doped Rare Earth Nanoparticles for Near‐infrared‐ii Imaging and Cancer Therapy

A Versatile Imaging and Therapeutic Platform Based on Dual-Band Luminescent Lanthanide Nanoparticles toward Tumor Metastasis Inhibition.

Rational Design of High Performance Nanotheranostics for NIR-II Fluorescence/magnetic Resonance Imaging Guided Enhanced Phototherapy.

915 nm Light-Triggered Photodynamic Therapy and MR/CT Dual-Modal Imaging of Tumor Based on the Nonstoichiometric Na0.52 YbF3.52 :Er Upconversion Nanoprobes

Rare Earth Nanoprobes for Targeted Delineation of Triple Negative Breast Cancer and Enhancement of Radioimmunotherapy

High-Performance Hybrid Phototheranostics for NIR-IIb Fluorescence Imaging and NIR-II-Excitable Photothermal Therapy.

Intelligent Nanotransducer for Deep-Tumor Hypoxia Modulation and Enhanced Dual-Photosensitizer Photodynamic Therapy

Prussian blue-coated lanthanide-doped core/shell/shell nanocrystals for NIR-II image-guided photothermal therapy